Pantothenate kinase-associated neurodegeneration in Korea: Recurrent R440P mutation in PANK2 and outcome of deep brain stimulation

European Journal of Neurology

Volumn 19, Issue 4, 2012, Pages 556-561

  Lim, B C ^a   Ki, C S ^b   Cho, A ^a   Hwang, H ^a   Kim, K J ^a   Hwang, Y S ^a   Kim, Y E ^a   Yun, J Y ^a   Jeon, B S ^a   Lim, Y H ^a   Paek, S H ^a   Chae, J H ^a  

^a Seoul National University Children's Hospital   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Deep brain stimulation; Korea; PANK2; Pantothenate kinase associated neurodegeneration

Indexed keywords

PANTOTHENATE KINASE 2;

ARTICLE; BRAIN DEPTH STIMULATION; CLINICAL ARTICLE; DISABILITY SEVERITY; DISEASE SEVERITY; DYSTONIA; FOLLOW UP; FRAMESHIFT MUTATION; GAIT DISORDER; GENOTYPE; HUMAN; KOREA; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; PANTOTHENATE KINASE ASSOCIATED NEURODEGENERATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RIGIDITY; SPASTICITY;

ADOLESCENT; ADULT; AGED; ARGININE; CHILD; DEEP BRAIN STIMULATION; DISABILITY EVALUATION; DNA MUTATIONAL ANALYSIS; FEMALE; GLOBUS PALLIDUS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MUTATION; PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); PROLINE; REPUBLIC OF KOREA; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84858148964     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2011.03589.x     Document Type: Article

References (18)

1. Gregory A, Polster BJ, Hayflick SJ. Clinical and genetic delineation of neurodegeneration with brain iron accumulation. J Med Genet 2009; 46: 73-80.
2. Hayflick SJ, Westaway SK, Levinson B, et al. Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome. N Engl J Med 2003; 348: 33-40.
3. Zhou B, Westway SK, Levinson B, et al. A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. Nat Genet 2001; 28: 345-349.
4. Thomas M, Hayflick SJ, Jankovic J. Clinical heterogeneity of neurodegeneration with brain iron accumulation (Hallervorden-Spatz syndrome) and pantothenate kinase-associated neurodegeneration. Mov Disord 2004; 19: 36-42.
5. Seo JH, Song SK, Lee PH. A novel PANK2 mutation in a patient with atypical pantothenate-kinase-associated neurodegeneration presenting with adult-onset Parkinsonism. J Clin Neurol 2009; 5: 192-194.
6. Yoon WT, Lee WY, Shin HY, Lee ST, Ki CS. Novel PANK2 gene mutations in korean patient with pantothenate kinase-associated neurodegeneration presenting unilateral dystonic tremor. Mov Disord 2010; 25: 245-247.
7. Timmermann L, Pauls KA, Wieland K, et al. Dystonia in neurodegeneration with brain iron accumulation: outcome of bilateral pallidal stimulation. Brain 2010; 133: 701-712.
8. Ng PC, Henikoff S. SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res 2003; 31: 3812-3814.
9. Krack P, Batir A, Van Blercom N, et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 2003; 349: 1925-1934.
10. Burke RE, Fahn S, Marsden CD, et al. Validity and reliability of a rating scale for the primary torsion dystonias. Neurology 1985; 35: 73-77.
11. Hartig MB, Hortnagel K, Garavaglia B, et al. Genotypic and phenotypic spectrum of PANK2 mutations in patients with neurodegeneration with brain iron accumulation. Ann Neurol 2006; 59: 248-256.
12. Umemura A, Jaggi JL, Dolinskas CA, Stern MB, Baltuch GH. Pallidal deep brain stimulation for longstanding severe generalized dystonia in Hallervorden-Spatz syndrome. Case report. J Neurosurg 2004; 100: 706-709.
13. Krause M, Fogel W, Tronnier V, et al. Long-term benefit to pallidal deep brain stimulation in a case of dystonia secondary to pantothenate kinase-associated neurodegeneration. Mov Disord 2006; 21: 2255-2257.
14. Shields DC, Sharma N, Gale JT, Eskandar EN. Pallidal stimulation for dystonia in pantothenate kinase-associated neurodegeneration. Pediatr Neurol 2007; 37: 442-445.
15. Mikati MA, Yehya A, Darwish H, Karam P, Comair Y. Deep brain stimulation as a mode of treatment of early onset pantothenate kinase-associated neurodegeneration. Eur J Paediatr Neurol 2009; 13: 61-64.
16. Isaac C, Wright I, Bhattacharyya D, Baxter P, Rowe J. Pallidal stimulation for pantothenate kinase-associated neurodegeneration dystonia. Arch Dis Child 2008; 93: 239-240.
17. Castelnau P, Cif L, Valente EM, et al. Pallidal stimulation improves pantothenate kinase-associated neurodegeneration. Ann Neurol 2005; 57: 738-741.
18. Vasques X, Cif L, Gonzalez V, Nicholson C, Coubes P. Factors predicting improvement in primary generalized dystonia treated by pallidal deep brain stimulation. Mov Disord 2009; 24: 846-853.